Incidence of multiple sclerosis in multiple racial and ethnic groups

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Neurology

• Publication date

  2013-05-07

• Fields of study

  Medicine

• Identifiers
  DOI 10.1212/WNL.0b013e3182918cc2PMID 23650231
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Clinical and Demographic Predictors of Long-term Disability in Patients With Relapsing-Remitting Multiple Sclerosis

  2015cited by this paper
• The Gulf War era multiple sclerosis cohort: age and incidence rates by race, sex and service.

  2012cited by this paper
• Offspring number, pregnancy, and risk of a first clinical demyelinating event

  2012cited by this paper
• Sociodemographic characteristics of members of a large, integrated health care system: comparison with US Census Bureau data.

  2012cited by this paper
• Diagnostic criteria for multiple sclerosis: 2010 Revisions to the McDonald criteria

  2011influential reference
• Incidence of acquired CNS demyelinating syndromes in a multiethnic cohort of children

  2011cited by this paper
• Smoking and increased risk of multiple sclerosis: parallel trends in the sex ratio reinforce the evidence.

  2011cited by this paper
• Using the Census Bureau’s surname list to improve estimates of race/ethnicity and associated disparities

  2009cited by this paper
• Multiple sclerosis susceptibility alleles in African Americans

  2009cited by this paper
• Expression of the Multiple Sclerosis-Associated MHC Class II Allele HLA-DRB1*1501 Is Regulated by Vitamin D

  2009cited by this paper
• Environmental factors and multiple sclerosis.

  2008cited by this paper
• Assessing the vitamin D status of the US population.

  2008cited by this paper
• Risk alleles for multiple sclerosis identified by a genomewide study.

  2007cited by this paper
• Variation in interleukin 7 receptor α chain (IL7R) influences risk of multiple sclerosis

  2007cited by this paper
• Clinical and demographic predictors of long-term disability in patients with relapsing-remitting multiple sclerosis: a systematic review.

  2006cited by this paper
• Serum 25-hydroxyvitamin D levels and risk of multiple sclerosis.

  2006influential reference
• Multiple sclerosis genetics: leaving no stone unturned

  2005cited by this paper
• The prevalence of multiple sclerosis in the world: an update

  2001cited by this paper
• Epidemiology of multiple sclerosis.

  1996cited by this paper
• Is the frequency of multiple sclerosis increasing in Mexico?

  1995cited by this paper
• Epidemiology of multiple sclerosis in U.S. veterans

  1979cited by this paper

• The pursuit of happiness: Social participation and happiness among minority individuals with multiple sclerosis.

  2026cites this paper
• Anti-aging and Anti-inflammatory Dietary Interventions in Multiple Sclerosis: A Narrative Review.

  2026cites this paper
• A Qualitative Inquiry of Exercise Preferences among Hispanic Adults with Multiple Sclerosis.

  2025cites this paper
• The TRaditional versus Early Aggressive Therapy for MS (TREAT-MS) trial: Design and baseline characteristics of participants.

  2025cites this paper
• The hidden toll: Atrophy of key central nervous system relays in African American women with multiple sclerosis.

  2025cites this paper
• Applying an Ethical Lens to the Treatment of People With Multiple Sclerosis.

  2025cites this paper
• Incidence and prevalence of neuromyelitis optica spectrum disorder in a contemporary, multi-ethnic cohort

  2025cites this paper
• Embodiment of structural racism and multiple sclerosis risk and outcomes in the USA

  2025influential citation
• Tolebrutinib for secondary progressive multiple sclerosis: A summary from the Institute for Clinical and Economic Review's California Technology Assessment Forum.

  2025cites this paper
• The 2024 Update to the McDonald Criteria for Multiple Sclerosis Diagnosis: A Guide for Radiologists.

  2025cites this paper
• The Relationship Between Multiple Sclerosis and Obesity: A Comparative Study

  2025cites this paper
• Migraines, the multiple sclerosis prodrome, and multiple sclerosis susceptibility

  2025cites this paper
• Health disparities in neurology

  2025cites this paper
• Real-World Treatment Outcomes in Black, Hispanic, Asian, and White People with Multiple Sclerosis Treated with Fumarates in the USA

  2025cites this paper
• Disparities in Imaging and Management of Multiple Sclerosis: A Review.

  2025cites this paper
• B cell-extrinsic and intrinsic factors linked to early immune repletion after anti-CD20 therapy in patients with multiple sclerosis of African ancestry

  2025cites this paper
• Earlier age of onset of multiple sclerosis in Asian patients in a Northeastern United States cohort.

  2025cites this paper
• A Cross-Sectional Study of Delayed Diagnosis Associated with Gender and Racial Identity in Multiple Sclerosis.

  2025cites this paper
• Pediatric multiple sclerosis: Improving outcome through high-efficacy therapies

  2025cites this paper
• Genetic Association and Causal Effects Between Obesity and Multiple Sclerosis: A Robust Two-Sample Mendelian Randomization Study

  2025cites this paper
• Factors associated with delay to diagnosis of multiple sclerosis in Zambia

  2025cites this paper
• Influence of race and gender on variability in clinical decision-making in neurology

  2025cites this paper
• Racial Inequities, Multiple Sclerosis, and Implementation of a Novel Treatment Algorithm at the Health System Level

  2025cites this paper
• Cost-Utility Analysis and Efficiency Frontier of Drugs Available in Brazil for the Treatment of Relapsing-Remitting Multiple Sclerosis.

  2025cites this paper
• The overall and smoking-attributable burden of multiple sclerosis among older adults aged 65–89 years from 1990 to 2019 and predictions to 2040

  2024cites this paper
• Early clinical effect of cladribine in patients with highly active multiple sclerosis in Mexico

  2024cites this paper
• Clinical characteristics and disease burden of African, Caribbean, and Black people with multiple sclerosis in Toronto, Canada.

  2024cites this paper
• Association of Social Determinants of Health With Brain MRI Outcomes in Individuals With Pediatric Onset Multiple Sclerosis

  2024cites this paper
• Exploring Pain on Social Media: Observational Study on Perceptions and Discussions of Chronic Pain Conditions

  2024cites this paper
• Subjective Well-Being, Positive Affect, Life Satisfaction, and Happiness With Multiple Sclerosis: A Scoping Review of the Literature

  2024influential citation
• Racial and Ethnic Disparities in Neurological Care in the United States

  2024influential citation
• Race and ethnicity in multiple sclerosis phase 3 clinical trials: A systematic review

  2024cites this paper
• Using a Patient-Centered Multicriteria Decision Analysis to Assess the Value of Multiple Sclerosis Treatments in the US: A Study Protocol

  2024cites this paper
• Building an ethnically and racially diverse neurology workforce

  2024cites this paper
• The relationship between ethnicity and multiple sclerosis characteristics in the United Kingdom: A UK MS Register study

  2024cites this paper
• Shifting patterns of multiple sclerosis treatment in a highly prevalent United States population

  2024cites this paper
• The intersection of race and sex on the clinical and cognitive progression of multiple sclerosis.

  2024cites this paper
• Endogenous retroviruses in multiple sclerosis: a network-based etiopathogenic model.

  2024cites this paper
• Interpretable and Intuitive Machine Learning Approaches for Predicting Disability Progression in Relapsing-Remitting Multiple Sclerosis Based on Clinical and Gray Matter Atrophy Indicators.

  2024cites this paper
• Racial and Ethnic Disease Phenotype Differences Are Driven by Genetics: No

  2024cites this paper
• A comparison of multiple sclerosis disease characteristics across three genetically diverse Asian racial groups in Singapore

  2024cites this paper
• Therapeutic Potential of Curcuma Longa and Its Constituents Role in the Treatment of Multiple Sclerosis

  2024cites this paper
• The epidemiology and clinical presentation of seropositive neuromyelitis optica spectrum disorder in a US population

  2024cites this paper
• Imaging phenotypic differences in multiple sclerosis: at the crossroads of aging, sex, race, and ethnicity

  2024cites this paper
• Cross-ancestry genome-wide association studies of brain imaging phenotypes

  2024influential citation
• Descriptive Analysis of Health Disparities Between Black and White People With Multiple Sclerosis in the Deep South.

  2024cites this paper
• Triggering multiple sclerosis at conception and early gestation: The variation in ultraviolet radiation is as important as its intensity

  2023cites this paper
• Real-World Safety and Effectiveness After 5 Years of Dimethyl Fumarate Treatment in Black and Hispanic Patients with Multiple Sclerosis in ESTEEM

  2023cites this paper
• Smoking and multiple sclerosis risk in black people: A nested case-control study.

  2023cites this paper
• Racial and Ethnic Differences in the Severity of Sexual Dysfunction Symptoms in Patients with Multiple Sclerosis

  2023cites this paper
• Incorporating health equity in the neurology curriculum: Our experience.

  2023cites this paper
• Demographics and baseline disease characteristics of Black and Hispanic patients with multiple sclerosis in the open-label, single-arm, multicenter, phase IV CHIMES trial.

  2023cites this paper
• Current Updates on the Diagnosis and Management of Multiple Sclerosis for the General Neurologist

  2023influential citation
• Population-Based Estimates for the Prevalence of Multiple Sclerosis in the United States by Race, Ethnicity, Age, Sex, and Geographic Region

  2023cites this paper
• [A clinical case of multiple sclerosis with an episode of schizophrenia-like syndrome].

  2023cites this paper
• Multiple sclerosis in indigenous peoples of the Americas: A systematic review of incidence, prevalence, and outcomes.

  2023cites this paper
• Mapping two decades of multiple sclerosis rehabilitation trials: A systematic scoping review and call to action to advance the study of race and ethnicity in rehabilitation research.

  2023cites this paper
• Health Disparities in Multiple Sclerosis among Hispanic and Black Populations in the United States

  2023cites this paper
• Targeted exercise for African-Americans with multiple sclerosis: Project TEAAMS.

  2023cites this paper
• Effectiveness of ocrelizumab on clinical and MRI outcome measures in multiple sclerosis across black and white cohorts: A single-center retrospective study.

  2023cites this paper
• Ethnic disparities in the epidemiological and clinical characteristics of multiple sclerosis.

  2023cites this paper
• Differential DNA methylation associated with multiple sclerosis and disease modifying treatments in an underrepresented minority population

  2023cites this paper
• Global, regional, and national burden of multiple sclerosis from 1990 to 2019: Findings of global burden of disease study 2019

  2023cites this paper
• A narrative review of neuro-ophthalmologic disease in African Americans and Hispanics with multiple sclerosis

  2023cites this paper
• An Atypical Presentation of Progressive Multiple Sclerosis in a Young Black Male

  2023cites this paper
• Treatment Patterns by Race and Ethnicity in Newly Diagnosed Persons with Multiple Sclerosis

  2023cites this paper
• The effect of disease modifying therapies on fatigue in multiple sclerosis.

  2023cites this paper
• Social determinants of health and disparate disability accumulation in a cohort of Black, Hispanic, and White patients with multiple sclerosis

  2023cites this paper
• Multiple sclerosis: Implications for the primary care NP.

  2023cites this paper
• Preliminary race-ethnicity-based analyses of fall risk among people with multiple sclerosis.

  2023cites this paper
• Cellular and Molecular Evidence of Multiple Sclerosis Diagnosis and Treatment Challenges

  2023cites this paper
• Stress indicators in minorities with multiple sclerosis.

  2023cites this paper
• Understanding humoral immunity and multiple sclerosis severity in Black, and Latinx patients

  2023cites this paper
• Multiple Sclerosis in Black and Hispanic Populations: Serving the Underserved.

  2023cites this paper
• Long-term trajectories of ambulatory impairment in multiple sclerosis

  2023cites this paper
• Do magnetic resonance imaging features differ between persons with multiple sclerosis of various races and ethnicities?

  2023cites this paper
• Re-thinking race and geography in multiple sclerosis

  2023cites this paper
• Association of Multiple Sclerosis Prevalence With Sociodemographic, Health Systems, and Lifestyle Factors on a National and Regional Level

  2022cites this paper
• Epidemiology and Pathophysiology of Multiple Sclerosis

  2022cites this paper
• Genetics of multiple sclerosis: lessons from polygenicity.

  2022cites this paper
• Juvenile Idiopathic Arthritis, Uveitis and Multiple Sclerosis: Description of Two Patients and Literature Review

  2022cites this paper
• Racial disparities in hypertension management among multiple sclerosis patients.

  2022cites this paper
• Psychometrics of the Multiple Sclerosis and Magnetic Resonance Imaging Knowledge Patient Questionnaire: A Pilot Study

  2022cites this paper
• Global Distribution of Idiopathic Granulomatous Mastitis: A Scoping Review

  2022cites this paper
• Differences in MS clinical and epidemiological characteristics between Ashkenazi and non-Ashkenazi Jewish patients in Israel: a retrospective single center study

  2022cites this paper
• Optic neuritis: A South African hospital-based prospective study protocol

  2022cites this paper
• Rates and patterns of physical activity among Hispanics with multiple sclerosis in the NARCOMS Registry.

  2022cites this paper
• Towards a global view of multiple sclerosis genetics

  2022cites this paper
• Racial and Ethnic Disparities in Multiple Sclerosis Prevalence

  2022cites this paper
• Multiple Sclerosis Incidence in Black Patients

  2022cites this paper
• Genetics and functional genomics of multiple sclerosis

  2022cites this paper
• Pharmacokinetics/pharmacodynamics by race: Analysis of a peginterferon β-1a phase 1 study.

  2022cites this paper
• A Systematic Review of Tissue and Single Cell Transcriptome/Proteome Studies of the Brain in Multiple Sclerosis

  2022cites this paper
• Prevalence of multiple sclerosis and treatment utilization in a large, highly diverse population.

  2022cites this paper
• Pharmacokinetics/pharmacodynamics by Race: Analysis of a Peginterferon Beta-1a Phase I Study

  2022cites this paper
• The Impact of CYP2C9*11 Allelic Variant on the Pharmacokinetics of Phenytoin and (S)‐Warfarin

  2022cites this paper
• Role of the Bruton tyrosine kinase pathway in multiple sclerosis.

  2022cites this paper
• Enrollment of Non-White Participants and Reporting of Race and Ethnicity in Phase III Trials of Multiple Sclerosis DMTs

  2022cites this paper
• Non-White Participants Matter in White Matter Disease Studies

  2022cites this paper
• Mediterranean diet is linked to less objective disability in multiple sclerosis

  2022cites this paper